繁 | EN

Organization and Structure

The HKAPI was registered in accordance with the provisions of Section 5 of the Societies Ordinance on 20th June 1968. The Board of Directors is composed of a President, a Vice-President, five to eight board members and an Honorary Treasurer all elected at the Annual General Meeting. Several Task Forces are also set up for strategic initiatives and system betterment. The day-to-day management of the Association is carried out by the Senior Executive Director, supported by fellow colleagues.

HKAPI Organization Chart

For more details, please click on the circles.

Executive Office

Board of Directors

Code of Practice
Committee

Sustainable
Financing

Operational
Working Groups

Solidify the
Industry’s Public
Image & Reputatuion

Improve
Healthcare System

Elevate HK’s
Value Proposition

Regulatory
Affairs

Human
Resources

HK
Pharmacademy

Ethics and
Compliance

Communications
Working Group

CDCC & Community
Drug Formulary

Role of Community
Pharmacies in HK

Drug Enlistment &
Reimbursement in HA

PSP Communication
via DPMS in HA

PSP Archetype for
Hong Kong Environment

Clinical trial
(Hong Kong focus)

Clinical trial
(GBA focus)

SCAN 2030

GBA

Executive Office

Board of Directors

Code of Practice
Committee

Human Resources Committee

Sustainable
Financing

Operational Working Groups/Committee

Primary Healthcare Taskforce

Patient Journey Navigation Taskforce

Regulatory
Working Group

Ethics and
Compliance
Working Group

Communications Working Group

Strategic Initiatives to Develop
Value Proposition of the Industry

Partnering for
Medical Advancement Taskforce

GBA
Taskforce

Close Bitnami banner
Bitnami